Highbridge Capital Management’s Aimei Health Technology Right AFJKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-871,784
Closed -$296K – 449
2026
Q2
$296K Sell
871,784
-1,260
-0.1% -$351 0.01% 247
2026
Q1
$275K Sell
873,044
-26,956
-3% -$10K 0.01% 172
2025
Q4
$360K Buy
900,000
+256,342
+40% +$96.6K 0.01% 142
2025
Q3
$193K Sell
643,658
-100
-0% -$36 0.01% 144
2025
Q2
$155K Hold
643,758
– – 0.01% 162
2025
Q1
$232K Sell
643,758
-900
-0.1% -$231 0.01% 124
2024
Q4
$110K Hold
644,658
– – ﹤0.01% 194
2024
Q3
$148K Hold
644,658
– – ﹤0.01% 176
2024
Q2
$148K Hold
644,658
– – ﹤0.01% 161
2024
Q1
$129K Buy
+644,658
New +$128K ﹤0.01% 165

Other funds holding AFJKR

Highbridge Capital Management's AFJKR Position: Q3 2026 in Review

Highbridge Capital Management sold out of Aimei Health Technology Right (AFJKR) in Q3 2026, closing a stake of 871,784 shares — an estimated $296K sold.

Highbridge Capital Management first reported a position in AFJKR in Q1 2024 and held it in 10 quarters. The position peaked at $360K in Q4 2025. 15 funds tracked by Wall St. Rank hold AFJKR as of Q3 2026.

  • Highbridge Capital Management reported no remaining Aimei Health Technology Right position as of Q3 2026 after selling out during the quarter.
  • Highbridge Capital Management sold 871,784 Aimei Health Technology Right shares in Q3 2026, an estimated $296K.
  • Highbridge Capital Management first reported a position in Aimei Health Technology Right in Q1 2024 and held it in 10 quarters.
  • Highbridge Capital Management's Aimei Health Technology Right position peaked at $360K in Q4 2025.
  • 15 funds tracked by Wall St. Rank held Aimei Health Technology Right as of Q3 2026.

Based on Highbridge Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.